147 related articles for article (PubMed ID: 37024846)
1. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
Huang Q; Li F; Ji M; Lin L; Hu C
BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
[TBL] [Abstract][Full Text] [Related]
2. Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.
Zhu X; Jamshed S; Zou J; Azar A; Meng X; Bathini V; Dresser K; Strock C; Yalamarti B; Yang M; Tomaszewicz K; Tjionas G; Mochel MC; Hutchinson L; Bledsoe JR
Mod Pathol; 2021 May; 34(5):1017-1030. PubMed ID: 33483624
[TBL] [Abstract][Full Text] [Related]
3. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
Wang Z; Xia RH; Ye DX; Li J
PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
[TBL] [Abstract][Full Text] [Related]
5. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
Kashofer K; Regauer S
Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
[TBL] [Abstract][Full Text] [Related]
6. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
Omura G; Ando M; Ebihara Y; Saito Y; Kobayashi K; Fukuoka O; Akashi K; Yoshida M; Asakage T; Yamasoba T
BMC Cancer; 2017 Dec; 17(1):898. PubMed ID: 29282038
[TBL] [Abstract][Full Text] [Related]
8. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53.
Meulendijks D; Tomasoa NB; Dewit L; Smits PH; Bakker R; van Velthuysen ML; Rosenberg EH; Beijnen JH; Schellens JH; Cats A
Br J Cancer; 2015 Apr; 112(8):1358-66. PubMed ID: 25871546
[TBL] [Abstract][Full Text] [Related]
9. LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
Casarotto M; Lupato V; Giurato G; Guerrieri R; Sulfaro S; Salvati A; D'Angelo E; Furlan C; Menegaldo A; Baboci L; Montico B; Turturici I; Dolcetti R; Romeo S; Baggio V; Corrado S; Businello G; Guido M; Weisz A; Giacomarra V; Franchin G; Steffan A; Sigalotti L; Vaccher E; Boscolo-Rizzo P; Jerry P; Fanetti G; Fratta E
Clin Epigenetics; 2022 Dec; 14(1):171. PubMed ID: 36503584
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population.
Maruyama H; Yasui T; Ishikawa-Fujiwara T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Hongyo T; Inohara H
Cancer Sci; 2014 Apr; 105(4):409-17. PubMed ID: 24521534
[TBL] [Abstract][Full Text] [Related]
13. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
14. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
[TBL] [Abstract][Full Text] [Related]
15. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
16. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
[TBL] [Abstract][Full Text] [Related]
17. All-Exon TP53 Sequencing and Protein Phenotype Analysis Accurately Predict Clinical Outcome after Surgical Treatment of Head and Neck Squamous Cell Carcinoma.
Kobayashi K; Yoshimoto S; Matsumoto F; Ando M; Murakami N; Omura G; Fukasawa M; Matsumoto Y; Matsumura S; Akamatsu M; Hiraoka N; Eigitsu R; Mori T
Ann Surg Oncol; 2019 Jul; 26(7):2294-2303. PubMed ID: 30900104
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
[TBL] [Abstract][Full Text] [Related]
19. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status.
Benzerdjeb N; Tantot J; Blanchet C; Philouze P; Mekki Y; Lopez J; Devouassoux-Shisheboran M
Histopathology; 2021 Sep; 79(3):381-390. PubMed ID: 33560536
[TBL] [Abstract][Full Text] [Related]
20. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features.
Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C
Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
